Ligand · 107
107 · 4-[(7-oxo-7H-thiazolo[5,4-e]indol-8-ylmethyl)-amino]-N-pyridin-2-yl-benzenesulfonamide
107, 4-[(7-oxo-7H-thiazolo[5,4-e]indol-8-ylmethyl)-amino]-N-pyridin-2-yl-benzenesulfonamide (C21 H15 N5 O3 S2, 449.5 g/mol), in the MolNFT structures on GenesisL1: bound in 1 record (1 PDB entry). Every binding site with its residues…
- Component
- 107
- Formula
- C21 H15 N5 O3 S2
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
107 in 1 structure; the first of them:
- 7VTO · The crystal structure of PAK1 with the inhibitor GW8510 · 107 A601 · binds LYS275, ILE276, VAL284, ALA297, VAL328, MET344, GLU345, TYR346 and 6 more
Residues it binds most
LYS 2, ALA 2, LEU 2, VAL 2, GLU 2, THR 2, GLY 2, ILE 2, MET 2, TYR 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.